Coherus Biosciences | CHRS - DŁUG





DŁUG Zmiana Data
AbbVie USD 70.82B 2.04B 2026-06
Acadia Pharmaceuticals USD 73.85M 23.06M 2026-06
Akebia Therapeutics USD 46.51M 7.82M 2025-03
ALKERMES USD 1.57B 10.58M 2026-09
Alnylam Pharmaceuticals USD 2.48B 1.21B 2026-09
Amarin USD 0 0 2025-03
Amgen USD 57.3B 19M 2026-06
Baxter International USD 9.67B 20M 2026-06
Biogen USD 7.69B 398.3M 2026-09
BioMarin Pharmaceutical USD 4.19B 11.99M 2026-09
Bristol-Myers Squibb USD 42.88B 2.18B 2026-09
Coherus Biosciences USD 294.92M 1.25M 2025-03
Eli Lilly USD 54.91B 11.54B 2026-06
Fujifilm JPY 1.03T 104.2B 2026-03
Gilead Sciences USD 26.25B 4.07B 2026-06
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Merck USD 53.91B 4.79B 2026-06
Myriad Genetics USD 59.3M 19.7M 2025-03
Pacira USD 293.59M 69.53M 2026-09
Perrigo USD 3.29B 337.7M 2026-06
Pfizer USD 62.67B 523M 2026-09
PTC Therapeutics USD 2.84B 2.15B 2026-09
Regeneron Pharmaceuticals USD 2.71B 400K 2026-06
Sarepta Therapeutics USD 857.36M 188.48M 2026-09
Teva Pharmaceutical Industries USD 16.98B 110M 2026-09
Vertex Pharmaceuticals USD 6.48B 4.5B 2026-09
Xencor USD 170.11M 5.06M 2026-06
Zoetis USD 9.24B 0 2026-06